We are monitoring the impact of COVID-19 on MEA Biopharmaceuticals Market Get in touch with us for detailed analysis Know More
Pulished Date August, 2019
ID: 586
Share on
Share on

Middle-East and Africa Biopharmaceuticals Market Research Report – Segmented By Product Type, By Therapeutic Type & By Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis, Size, Share, Growth, Trends and Forecast (2019-2024)

Pulished: August, 2019
ID: 586
Pages: 145

MEA Biopharmaceuticals Market Size & Growth (2019 - 2024)

The size of the Biopharmaceuticals market in the Middle-East and Africa was worth USD 17.31 billion in 2019 and estimated to be growing at a CAGR of 9.16%, to reach USD 26.84 billion by 2024.

The pharmaceutical Research & Development industry is greatly dependent upon the biopharmaceutical drugs market for profit. Development of these products is being undertaken by a growing number of players in the pharmaceutical industry, which include the big pharma companies and also generic drug manufacturers, who are also engaged in developing biosimilars.

Biopharmaceuticals are in huge demand due to the growing incidence of chronic diseases, which is one of the key drivers, increasing the growth of the MEA biopharmaceuticals market. Chronic diseases are growing due to an unhealthy lifestyle, poor diet, excess alcohol consumption, and lack of physical activity.

The restraints related to the global biopharmaceuticals market include high cost of biopharmaceuticals and side effects, such as breathing problems, sore throat, allergic reactions, itching, and rashes due to the consumption of biopharmaceuticals.

This research report segmented and sub-segmented into the following categories:

  • By Product Type: Monoclonal Antibodies (mAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-stimulating Factor (G-CSF), Interferon And Human Growth Hormones (HGH)
  • By Therapeutic Type: Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular, And Other Therapeutic Areas
  • By Country: KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA

Regionally, the African biopharmaceuticals market is estimated to grow at the highest rate in the region.

Companies like Merck & Co., Inc., F. Hoffmann-La Roche AG, Eli Lilly and Company, Inc., Sanofi, Amgen Inc., AbbVie Inc., Biogen Idec, Bayer AG, Johnson & Johnson Services, Pfizer, Inc. and Novartis AG are playing a dominant role in the MEA Biopharmaceuticals Market.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 By Product Type                       

                                5.1.1 Monoclonal Antibodies (mAb)       

                                5.1.2 Erythropoietin       

                                5.1.3 Biotech Vaccines  

                                5.1.4 Recombinant Human (RH) Insulin 

                                5.1.5 Granulocyte colony-stimulating factor (G-CSF)       

                                5.1.6 Interferon               

                                5.1.7 Human growth hormones (HGH)  

                5.2 By Therapeutic Type                               

                                5.2.1 Neurology               

                                5.2.2 Infectious diseases              

                                5.2.3 Diabetes  

                                5.2.4 Oncology 

                                5.2.5 Cardiovascular       

                                5.2.6 Other Therapeutic Areas  

6. Geographical Analysis                                              

                6.1 Introduction                               

                6.2 Middle-East                                

                6.3 Africa                            

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Merck & Co.                               

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues             

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 F. Hoffmann-La Roche AG                    

                8.3 Eli Lilly and Company                              

                8.4 Sanofi                           

                8.5 Amgen Inc.                 

                8.6 AbbVie Inc.                 

                8.7 Biogen Idec                

                8.8 Bayer AG                     

                8.9 Johnson & Johnson Services                               

                8.10 Pfizer                          

                8.11 Novartis AG                             

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Expert Opinions                                        

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Middle East & Africa Biopharmaceuticals market By Region, From 2019-2024 (USD Billion)
  2. Middle East & Africa Biopharmaceuticals market By Product Type, From 2019-2024 (USD Billion)
  3. Middle East & Africa Monoclonal Antibodies (mAb) Market By Region, From 2019-2024 (USD Billion)
  4. Middle East & Africa Erythropoietin Market By Region, From 2019-2024 (USD Billion)
  5. Middle East & Africa Biotech Vaccines Market By Region, From 2019-2024 (USD Billion)
  6. Middle East & Africa Recombinant Human (RH) Insulin Market By Region, From 2019-2024 (USD Billion)
  7. Middle East & Africa Granulocyte colony-stimulating factor (G-CSF) Market By Region, From 2019-2024 (USD Billion)
  8. Middle East & Africa Interferon Market By Region, From 2019-2024 (USD Billion)
  9. Middle East & Africa Human growth hormones (HGH) Market By Region, From 2019-2024 (USD Billion)
  10. Middle East & Africa Biopharmaceuticals market By Therapeutic Type, From 2019-2024 (USD Billion)
  11. Middle East & Africa Neurology Market By Region, From 2019-2024 (USD Billion)
  12. Middle East & Africa Infectious diseases Market By Region, From 2019-2024 (USD Billion)
  13. Middle East & Africa Diabetes Market By Region, From 2019-2024 (USD Billion)
  14. Middle East & Africa Oncology Market By Region, From 2019-2024 (USD Billion)
  15. Middle East & Africa Cardiovascular Market By Region, From 2019-2024 (USD Billion)
  16. Middle East & Africa Other Therapeutic Areas Market By Region, From 2019-2024 (USD Billion)
  17. Middle East Biopharmaceuticals market By Product Type, From 2019-2024 (USD Billion)
  18. Middle East Biopharmaceuticals market By Therapeutic Type, From 2019-2024 (USD Billion)
  19. Africa Biopharmaceuticals market By Product Type, From 2019-2024 (USD Billion)
  20. Africa Biopharmaceuticals market By Therapeutic Type, From 2019-2024 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample